These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 19874215)

  • 1. Elevated plasma concentration of NO and cGMP may be responsible for the decreased platelet aggregation and platelet leukocyte conjugation in platelets hypo-responsive to catecholamines.
    Koo YK; Kim JM; Kim SY; Koo JY; Oh D; Park S; Yun-Choi HS
    Platelets; 2009 Dec; 20(8):555-65. PubMed ID: 19874215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct inhibition of platelet function by organic nitrates via nitric oxide formation.
    Weber AA; Strobach H; Schrör K
    Eur J Pharmacol; 1993 Sep; 247(1):29-37. PubMed ID: 8258358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of antiplatelet drugs in vitro: aspirin, iloprost, and the nitric oxide donors SIN-1 and sodium nitroprusside.
    Negrescu EV; Grünberg B; Kratzer MA; Lorenz R; Siess W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):619-29. PubMed ID: 8547213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP.
    Qi R; Ozaki Y; Satoh K; Yang LB; Asazuma N; Yatomi Y; Kume S
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):215-22. PubMed ID: 8856476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential inhibition of human platelet aggregation and thromboxane A2 formation by L-arginine in vivo and in vitro.
    Bode-Böger SM; Böger RH; Galland A; Frölich JC
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):143-50. PubMed ID: 9521487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of inorganic nitrate and nitrite in driving nitric oxide-cGMP-mediated inhibition of platelet aggregation in vitro and in vivo.
    Apostoli GL; Solomon A; Smallwood MJ; Winyard PG; Emerson M
    J Thromb Haemost; 2014 Nov; 12(11):1880-9. PubMed ID: 25163536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
    Fisch A; Michael-Hepp J; Meyer J; Darius H
    Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncocalyxone A inhibits human platelet aggregation by increasing cGMP and by binding to GP Ibalpha glycoprotein.
    Ferreira MA; do Nascimento NR; de Sousa CM; Pessoa OD; de Lemos TL; Ventura JS; Schattner M; Chudzinski-Tavassi AM
    Br J Pharmacol; 2008 Jul; 154(6):1216-24. PubMed ID: 18516074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.
    Anfossi G; Mularoni EM; Burzacca S; Ponziani MC; Massucco P; Mattiello L; Cavalot F; Trovati M
    Diabetes Care; 1998 Jan; 21(1):121-6. PubMed ID: 9538982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressed anti-aggregating and cGMP-elevating effects of sodium nitroprusside in platelets from patients with stable angina pectoris.
    Chirkov YY; Chirkova LP; Horowitz JD
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):520-5. PubMed ID: 8897457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content.
    Anfossi G; Russo I; Massucco P; Mattiello L; Balbo A; Cavalot F; Trovati M
    Thromb Res; 2001 May; 102(4):319-30. PubMed ID: 11369425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost.
    Anfossi G; Massucco P; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Prostaglandins Leukot Essent Fatty Acids; 1993 Nov; 49(5):839-45. PubMed ID: 7508131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet effect of the anaesthetic drug propofol: influence of red blood cells and leucocytes.
    De La Cruz JP; Páez MV; Carmona JA; De La Cuesta FS
    Br J Pharmacol; 1999 Dec; 128(7):1538-44. PubMed ID: 10602334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet aggregation by chlorogenic acid via cAMP and cGMP-dependent manner.
    Cho HJ; Kang HJ; Kim YJ; Lee DH; Kwon HW; Kim YY; Park HJ
    Blood Coagul Fibrinolysis; 2012 Oct; 23(7):629-35. PubMed ID: 22885765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of trilinolein on cyclic nucleotide formation in human platelets: relationship with its antiplatelet effect and nitric oxide synthesis.
    Shen YC; Hong CY
    Br J Pharmacol; 1995 Sep; 116(1):1644-8. PubMed ID: 8564231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro inhibition of human and rat platelets by NO donors, nitrosoglutathione, sodium nitroprusside and SIN-1, through activation of cGMP-independent pathways.
    Priora R; Margaritis A; Frosali S; Coppo L; Summa D; Di Giuseppe D; Aldinucci C; Pessina G; Di Stefano A; Di Simplicio P
    Pharmacol Res; 2011 Sep; 64(3):289-97. PubMed ID: 21539916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrovasodilators and cGMP inhibit human platelet activation.
    Doni MG; Alexandre A; Padoin E; Bertoncello S; Deana R
    Cardioscience; 1991 Sep; 2(3):161-5. PubMed ID: 1660321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential role for extracellular nitric oxide generation in cGMP-independent inhibition of human platelet aggregation: biochemical and pharmacological considerations.
    Crane MS; Rossi AG; Megson IL
    Br J Pharmacol; 2005 Mar; 144(6):849-59. PubMed ID: 15685209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous GTP increases cyclic GMP and inhibits thrombin-induced aggregation of washed human platelets: comparison with ATP, adenosine and guanosine.
    Vuorinen P; Laustiola KE
    Pharmacol Toxicol; 1992 Oct; 71(4):289-93. PubMed ID: 1333596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.